Need Help?
No Article Versions Notes Found
Cite
Lukka, H.; Waldron, T.; Klotz, L.; Winquist, E.; Trachtenberg, J.; on behalf of the Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care. Maximal Androgen Blockade for the Treatment of Metastatic Prostate Cancer—A Systematic Review. Curr. Oncol. 2006, 13, 81-93. https://doi.org/10.3747/co.v13i3.85
Lukka H, Waldron T, Klotz L, Winquist E, Trachtenberg J, on behalf of the Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care. Maximal Androgen Blockade for the Treatment of Metastatic Prostate Cancer—A Systematic Review. Current Oncology. 2006; 13(3):81-93. https://doi.org/10.3747/co.v13i3.85
Chicago/Turabian StyleLukka, H., T. Waldron, L. Klotz, E. Winquist, J. Trachtenberg, and on behalf of the Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care. 2006. "Maximal Androgen Blockade for the Treatment of Metastatic Prostate Cancer—A Systematic Review" Current Oncology 13, no. 3: 81-93. https://doi.org/10.3747/co.v13i3.85
APA StyleLukka, H., Waldron, T., Klotz, L., Winquist, E., Trachtenberg, J., & on behalf of the Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care. (2006). Maximal Androgen Blockade for the Treatment of Metastatic Prostate Cancer—A Systematic Review. Current Oncology, 13(3), 81-93. https://doi.org/10.3747/co.v13i3.85
